Q3 2026 Holdings
Filed 2026-10-21 | 44 holdings | $145.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ishares TR(SGOV) | 0-3 MTH TREASURY | 46436E718 | $70.5M | 700,000 | 48.3% |
| Spdr Series Trust(XBI) | ST STR SP BIOT | 78464A870 | $60.9M | 386,500 | 41.8% |
| Sera Prognostics Inc(SERA) | CLASS A COM | 81749D107 | $5.0M | 2,396,685 | 3.4% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $331.2K | 3,000 | 0.2% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $302.4K | 600 | 0.2% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $292.1K | 5,000 | 0.2% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $291.8K | 5,000 | 0.2% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $287.7K | 300 | 0.2% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $284.5K | 12,000 | 0.2% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $278.9K | 5,000 | 0.2% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $275.1K | 3,500 | 0.2% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $274.8K | 7,000 | 0.2% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $264.3K | 10,000 | 0.2% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $261.1K | 3,500 | 0.2% |
| Supernus Pharmaceuticals(SUPN) | COM | 868459108 | $258.2K | 6,000 | 0.2% |
| Immunome Inc(IMNM) | COM | 45257U108 | $258.1K | 12,000 | 0.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $255.3K | 1,800 | 0.2% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $249.9K | 3,000 | 0.2% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $249.5K | 10,000 | 0.2% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $247.4K | 6,500 | 0.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $246.3K | 1,200 | 0.2% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $243.1K | 6,000 | 0.2% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $242.9K | 15,000 | 0.2% |
| Incyte Corp(INCY) | COM | 45337C102 | $242.7K | 2,000 | 0.2% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $241.2K | 20,000 | 0.2% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $236.5K | 7,000 | 0.2% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $234.0K | 9,000 | 0.2% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $230.1K | 692 | 0.2% |
| Ascendis Pharma A/S(ASND) | ORD SHS | K08588103 | $227.8K | 1,000 | 0.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $225.6K | 12,000 | 0.2% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $223.6K | 2,000 | 0.2% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $220.1K | 2,500 | 0.2% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $214.8K | 15,000 | 0.1% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $213.7K | 2,500 | 0.1% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $212.0K | 7,000 | 0.1% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $211.3K | 1,500 | 0.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $203.0K | 5,000 | 0.1% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $175.1K | 13,000 | 0.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $161.1K | 10,000 | 0.1% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $124.4K | 10,000 | 0.1% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $115.1K | 15,000 | 0.1% |
| Cytomx Therapeutics Inc.(CTMX) | COM | 23284F105 | $107.2K | 39,400 | 0.1% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $102.6K | 30,000 | 0.1% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $86.4K | 10,000 | 0.1% |